The DOI matches its Crossref record; 106 of the 108 references it cites were found in a registry or an index; 32 of the 122 sources its claims cite were checked for support.
A Review on Fucoidan Structure, Extraction Techniques, and Its Role as an Immunomodulatory Agent
Open accessAbstract
This review addresses fucoidan structural complexity, extraction techniques, and immunomodulatory activity.
Overview
CoChat Summary
TL;DR
This is a narrative review of fucoidan from brown algae, covering its structural diversity, extraction/purification methods, impurities, and reported immunomodulatory and anti-inflammatory activities. The paper argues that fucoidan bioactivity depends strongly on structure and extraction conditions, but that standardized structures, mechanisms, and robust human evidence remain limited.
Key findings
- Fucoidans are heterogeneous sulfated polysaccharides with fucose as the core monomer; reported molecular weights are approximately 100–1600 kDa, and sulfate is commonly substituted at C2 or C4 and sometimes C3.
- Structural composition varies by algal species and extraction method; the review notes that this variability makes classification by algal order “paradoxical” and that refined structures are not yet clear for many species.
- Extraction conditions strongly affect yield and structure: temperature, time, pH, acid concentration, and purification steps can alter fucose/sulfate content, while impurities such as alginate, proteins, pigments, lipids, terpenes, and phenols must be removed.
- The review summarizes evidence that fucoidan can both suppress and stimulate immune responses, often through NF-κB, MAPK, TLRs, and JAK/STAT pathways; it cites, for example, a >30 kDa fraction from *S. horneri* inhibiting LPS-induced NO production (IC50 = 87.12 g/mL) and downregulating PGE2 and pro-inflammatory cytokines in RAW 264.7 cells.
Methods
- Narrative review of published studies on fucoidan structure, extraction techniques, impurities, and immunomodulatory/anti-inflammatory effects from marine brown algae.
- Synthesizes findings from prior structural analyses and extraction studies using methods such as anion-exchange chromatography, gel permeation chromatography, dialysis, ethanol precipitation, acid hydrolysis, enzymatic digestion, MAE, UAE, and carbohydrase-assisted extraction.
- Integrates in vitro, in vivo, and clinical reports to discuss structure–activity relationships and immune signaling pathways.
Limitations
- The paper states that refined structures are not yet clear for many fucoidans and that only a few reports have structurally elucidated selected species.
- It notes that most published research used relatively crude fucoidan preparations, which hinders structure–activity relationship analysis.
- The text explicitly says that most research requires successful human trials and that the number of clinical studies is limited, which impedes knowledge of fucoidan pharmacokinetics.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1 Structural diversity of fucose containing sulfated polysaccharides (FCSPs). Structural models proposed from Fucales, (a) Ascophyllum nodosum [18], (b) Fucus serratus [21]. Reported structural models from Laminariales, (c) Chorda filum [24], and the chemical structural model derived from order Chordariales (d) Cladosiphon okamuranus [8].](https://figures.cochat.ai/paper-figures/ab409b1b39a84cfcbc3a3be894797e44/a-review-on-fucoidan-structure-extraction-techniques-and-its-role-as-an-figure-1.jpg)

Verification
Claims the paper makes
28 Valid · 1 Not valid · 71 Not checked · 29 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Fucoidans are characterized by a sulfated fucose backbone.”
§ A Review on Fucoidan Structure, Extraction Techniques, and Its Role as an Immunomodulatory Agent > Abstract
What the sources say
- Not checked — no full text of the sourcecites [13] Jayawardena, 2019, Isolation and purification of fucoidan fraction in Turbinaria ornata from the Maldives; Inflammation inhibitory potential under LPS stimulated conditions in in-vitro and in-vivo models, Int. J. Biol. Macromol. source
- Not checked — no full text of the sourcecites [14] Zvyagintseva, 1999, A new procedure for the separation of water-soluble polysaccharides from brown seaweeds, Carbohyd. Res. source
- Partly supportedcites [15] Ale, 2011, Important determinants for fucoidan bioactivity: A critical review of structure-function relations and extraction methods for fucose-containing sulfated polysaccharides from brown seaweeds, Mar. Drugs sourceExperimental — accuracy not yet measured
The Introduction describes fucoidans as sulfated, fucose-rich polysaccharides that principally have a fucose backbone whose residues may carry sulfate. It also cautions that the class includes structures beyond those with fucan backbones, so the claim is too categorical. (LLM, conf=0.88)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The sulfate component is frequently substituted at either the C2 or C4 positions of L-fucopyranosyl residues and randomly at C3 [15].”
§ A Review on Fucoidan Structure, Extraction Techniques, and Its Role as an Immunomodulatory Agent > 2. Structure of Fucoidan
What the sources say
- Partly supportedcites [15] Ale, 2011, Important determinants for fucoidan bioactivity: A critical review of structure-function relations and extraction methods for fucose-containing sulfated polysaccharides from brown seaweeds, Mar. Drugs sourceExperimental — accuracy not yet measured
The Introduction says sulfate may substitute L-fucopyranose residues at C-2 or C-4, supporting the main part of the claim. It describes C-3 substitution as rare, not random; the claimed pattern at C-3 is therefore unsupported. (LLM, conf=0.88)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The fucose content, sulfate content, and point of sulfation, including the substitution of monomeric units in the backbone, have been reported to influence bioactivity [2,5].”
§ A Review on Fucoidan Structure, Extraction Techniques, and Its Role as an Immunomodulatory Agent > 1. Introduction
What the sources say
- Not checked — no full text of the sourcecites [2] Fernando, 2021, Low molecular weight fucoidan fraction ameliorates inflammation and deterioration of skin barrier in fine-dust stimulated keratinocytes, Int. J. Biol. Macromol. source
- Partly supportedcites [5] Jayawardena, T.U., Sanjeewa, K.K.A., Nagahawatta, D.P., Lee, H.G., Lu, Y.A., Vaas, A., Abeytunga, D.T.U., Nanayakkara, C.M., Lee, D.S., and Jeon, Y.J. (2020). Anti-Inflammatory Effects of Sulfated Polysaccharide from Sargassum Swartzii in Macrophages via Blocking TLR/NF-Kappab Signal Transduction. Mar. Drugs, 18. sourceExperimental — accuracy not yet measured
The Discussion links fucoidan structure to biological potential and reports that the F4 fraction, which was rich in fucose and sulfate, showed the strongest anti-inflammatory activity. The structural-characterization section identifies a sulfate substitution position, but the paper does not show that sulfation position or substitution of backbone monomers influences bioactivity. Page numbers are unavailable in our copy. (LLM, conf=0.84)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Every source the paper cites for this claim was checked and supports it.
In the paper
“The sulfate content in the active fucoidan fraction of S. swartzii was 33.99 ± 0.17%.”
§ A Review on Fucoidan Structure, Extraction Techniques, and Its Role as an Immunomodulatory Agent > 4. Immunomodulatory Effects
What the sources say
- Supportedcites [5] Jayawardena, T.U., Sanjeewa, K.K.A., Nagahawatta, D.P., Lee, H.G., Lu, Y.A., Vaas, A., Abeytunga, D.T.U., Nanayakkara, C.M., Lee, D.S., and Jeon, Y.J. (2020). Anti-Inflammatory Effects of Sulfated Polysaccharide from Sargassum Swartzii in Macrophages via Blocking TLR/NF-Kappab Signal Transduction. Mar. Drugs, 18. source
Section 2.1 reports that fraction F4 of S. swartzii contained 33.99 ± 0.17% sulfate. The Discussion identifies F4 as the most effective of the tested fractions in the initial bioactivity analysis, supporting its description as the active fraction. The indexed passages have no page numbers. (LLM, conf=0.95)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“According to this report, canonical p65 nuclear translocation was evident using immunofluorescence techniques.”
§ A Review on Fucoidan Structure, Extraction Techniques, and Its Role as an Immunomodulatory Agent > 4. Immunomodulatory Effects
What the sources say
- Supportedcites [5] Jayawardena, T.U., Sanjeewa, K.K.A., Nagahawatta, D.P., Lee, H.G., Lu, Y.A., Vaas, A., Abeytunga, D.T.U., Nanayakkara, C.M., Lee, D.S., and Jeon, Y.J. (2020). Anti-Inflammatory Effects of Sulfated Polysaccharide from Sargassum Swartzii in Macrophages via Blocking TLR/NF-Kappab Signal Transduction. Mar. Drugs, 18. source
The Methods section (4.7.3; page unavailable) describes immunofluorescent imaging of NF-κB p65 nuclear localization. The Discussion (page unavailable) says the immunofluorescence assay verified the finding that treatment reduced p50/p65 translocation to the nucleus in LPS-stimulated macrophages. (LLM, conf=0.90)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
41 more claims · 5 with their cited sources checked
Create a free account to see all 129 claims and to verify the 8 references still open.
- Probably not a substantial claim. 34
- It may state two separate claims as one. 63
- The quote only partly states this claim. 2
Citations
Cites
The L-Arginine-Nitric Oxide Pathway
Epstein, F. H., Moncada, S., & Higgs, A. (1993) · New England Journal of Medicine · doi:10.1056/nejm199312303292706 · Cited by 6,678 · cited 1×
“NO production exceeds regular levels in the presence of immunological reactions; thus, it is involved in pathogenesis [66].”
Shared Principles in NF-κB Signaling
Hayden, M. S., & Ghosh, S. (2008) · Cell · doi:10.1016/j.cell.2008.01.020 · Cited by 4,494
Points of control in inflammation
Nathan, C. (2002) · Nature · doi:10.1038/nature01320 · Cited by 2,738 · cited 1×
“Modulation of inflammation is an alternative approach, although pathogenic events are unknown [50].”
Secretory products of macrophages.
Nathan, C. F. (1987) · Journal of Clinical Investigation · doi:10.1172/jci112815 · Cited by 2,615
A colorimetric method for the determination of sugars
DUBOIS, M., GILLES, K., HAMILTON, J. K., REBERS, P. A., & SMITH, F. (1951) · Nature · doi:10.1038/168167a0 · Cited by 2,504 · cited 1×
“Ion-exchange chromatography produced four different fractions with considerable yields [22].”
Khovidhunkit, W., Kim, M.-S., Memon, R. A., Shigenaga, J. K., Moser, A. H., Feingold, K. R., & Grunfeld, C. (2004) · Journal of Lipid Research · doi:10.1194/jlr.r300019-jlr200 · Cited by 1,481 · cited 1×
“A diverse array of cytokines, signaling proteins, lipid molecules, and transcription factors are involved in immune functions [9].”
Fucoidan: Structure and bioactivity
Li, B., Lu, F., Wei, X., & Zhao, R. (2008) · Molecules · doi:10.3390/molecules13081671 · Cited by 1,383
Analytical-scale microwave-assisted extraction
Sparr Eskilsson, C., & Björklund, E. (2000) · Journal of Chromatography A · doi:10.1016/s0021-9673(00)00921-3 · Cited by 1,116
Prostaglandin E2 synthesis and secretion: The role of PGE2 synthases
Park, J. Y., Pillinger, M. H., & Abramson, S. B. (2006) · Clinical Immunology · doi:10.1016/j.clim.2006.01.016 · Cited by 793 · cited 1×
“Thus, the modulation of COX-2 is as important as that of iNOS in inflammatory pathogenesis [67].”
Ale, M. T., Mikkelsen, J. D., & Meyer, A. S. (2011) · Marine Drugs · doi:10.3390/md9102106 · Cited by 779
Cited by
Fu, Y., Jiao, H., Sun, J., Okoye, C. O., Zhang, H., Li, Y., Lu, X., Wang, Q., & Liu, J. (2023) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2023.121533 · Cited by 97
Marine-Derived Polysaccharides and Their Potential Health Benefits in Nutraceutical Applications
Carrasqueira, J., Bernardino, S. M. S. A., Bernardino, R., & Afonso, C. (2025) · Marine Drugs · doi:10.3390/md23020060 · Cited by 78
Functions and values of sulfated polysaccharides from seaweed
Nagahawatta, D. P., Liyanage, N. M., Jayawardena, T. U., Yang, F., Jayawardhana, H. H. A. C. K., Kurera, M. J. M. S., Wang, F., Fu, X., & Jeon, Y. (2023) · ALGAE · doi:10.4490/algae.2023.38.12.1 · Cited by 89
Self-citationRoy, V. C., Islam, M. R., Sadia, S., Yeasmin, M., Park, J., Lee, H.-J., & Chun, B. (2023) · Marine Drugs · doi:10.3390/md21090485 · Cited by 81
A Comparative Review of Alternative Fucoidan Extraction Techniques from Seaweed
Chadwick, M., Carvalho, L. G., Vanegas, C., & Dimartino, S. (2025) · Marine Drugs · doi:10.3390/md23010027 · Cited by 72
Metadata
- Authors
- Jayawardena, T. U., Nagahawatta, D. P., Fernando, I. P. S., Kim, Y.-T., Kim, J.-S., Kim, W.-S., Lee, J. S., & Jeon, Y.-J.
- Affiliations
- Université du Québec à Trois-Rivières (CA)
- Jeju National University (KR)
- University of Alberta (CA)
- Kunsan National University (KR)
- Gyeongsang National University (KR)
- Silla University (KR)
- Corresponding author
- Lee, Jung Suck
- Jeon, You-Jin
- ORCID
- Venue
- Marine Drugs
- Publisher
- MDPI AG
- Published
- 2022-11-30
- Volume
- 20
- Issue
- 12
- Pages
- 755
- ISSN
- 1660-3397 (ISSN-L)
- PMC
- PMC9782291
- OpenAlex
- W4310382559
- Cited by
- 149
- References
- 108
- Citations by year
- 2026: 43 · 2025: 46 · 2024: 38 · 2023: 22
- FWCI
- 2.25
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Marine Drugs (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Ministry of Oceans and Fisheries (20220488)
- Topics
- Life Sciences › Agricultural and Biological Sciences › Aquatic Science › Seaweed-derived Bioactive Compounds
- Life Sciences › Agricultural and Biological Sciences › Food Science › Polysaccharides Composition and Applications
- Health Sciences › Medicine › Pharmacology (medical) › Fungal Biology and Applications
- Keywords
- fucoidan, marine brown algae, polysaccharide extraction and purification, polysaccharide structure, immunomodulation, immune cell signaling, inflammation, functional food ingredients, sulfated polysaccharides
- MeSH terms
- Phaeophyceae, Fucose, Humans, Immunologic Factors, Polysaccharides, Seaweed, Sulfates
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A Review on Fucoidan Structure, Extraction Techniques, and Its Role as an Immunomodulatory Agent. https://app.cochat.ai/papers/10.3390/md20120755
- The paper
- Jayawardena, T. U., Nagahawatta, D. P., Fernando, I. P. S., Kim, Y.-T., Kim, J.-S., Kim, W.-S., Lee, J. S., & Jeon, Y.-J. (2022). A Review on Fucoidan Structure, Extraction Techniques, and Its Role as an Immunomodulatory Agent. Marine Drugs. https://doi.org/10.3390/md20120755
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.